Characteristics | SLE (n=202) |
Systolic blood pressure, mm Hg (median, range) | 117 (109–126) |
Smoking, pack-years (mean±SD) | 10.3±14.6 |
Smoking current, n (%) | 71 (35.1) |
Family history of premature CΑD, n (%) | 20 (9.9) |
Total Cholesterol, mg/dL (mean±SD) | 183±40.9 |
HDL, mg/dL (mean±SD) | 60.6±20.6 |
LDL, mg/dL (mean±SD) | 103.6±32.9 |
Triglycerides, mg/dL (mean±SD) | 101.1±61.3 |
BMI, kg/m2 (median, IQR) | 24.6 (7.9) |
Exercise, min/week (mean, range) | 103 (0–720) |
Hypertension, n (%) | 73 (36.1) |
Dyslipidaemia, n (%) | 99 (49) |
Antihypertensives, n (%) | 63 (32) |
Statins, n (%) | 24 (11.9) |
Antiplatelet agents, n (%) | 57 (28.2) |
SCORE, median (IQR) | 1.7 (3) |
Plaque presence (carotid and/or femoral), n (%) | 52 (25.7) |
Carotid plaque presence, n (%) | 42 (20.8) |
Femoral plaque presence, n (%) | 35 (17.3) |
BMI, body mass index; CAD, coronary artery disease; HDL, high-density lipoprotein; LDL, low-density lipoprotein; LLDAS, lupus low disease activity state; SCORE, Systematic COronary Risk Evaluation prediction of 10-year fatal cardiovascular disease.